4-Chloroquinoline-8-sulfonyl chloride

Catalog No.: 
ACVPBG100
CAS No.: 
66533-26-4
Molecular Formula: 
C9H5Cl2NO2S
Molecular Weight: 
262.12
4-Chloroquinoline-8-sulfonyl chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$325.00InquiryInquiry
100mg95%$476.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloroquinoline-8-sulfonyl chloride
IUPAC Name4-chloroquinoline-8-sulfonyl chloride
MDL No.MFCD29034130
Molecular FormulaC9H5Cl2NO2S
Molecular Weight262.12
SMILESO=S(C1=C2N=CC=C(Cl)C2=CC=C1)(Cl)=O
InChI KeyFAHXJDSBGZMRHC-UHFFFAOYSA-N
Synonym4-chloroquinoline-8-sulfonyl chloride;8-Quinolinesulfonyl chloride, 4-chloro-
CAS No.66533-26-4

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACVPBG100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHVAP293 route compound structure diagram
    ACHVAP29365340-71-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPBG100 route product structure diagram
    ACVPBG10066533-26-4
Inquiry

2. ACVPBG100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHVAP293 route compound structure diagram
    ACHVAP29365340-71-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPBG100 route product structure diagram
    ACVPBG10066533-26-4
Inquiry

3. ACVPBG100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVPBG100 route product structure diagram
    ACVPBG10066533-26-4
Inquiry

Comments (0)